β-eudesmol, a sesquiterpene from Teucrium ramosissimum, inhibits superoxide production, proliferation, adhesion and migration of human tumor cell

Environmental Toxicology and Pharmacology

Volumn 46, Issue , 2016, Pages 227-233

  Ben Sghaier, Mohamed ^a   Mousslim, Mohamed ^b   Pagano, Alessandra ^b   Ammari, Youssef ^a   Luis, José ^b   Kovacic, Hervé ^b  

^a UNIVERSITY OF CARTHAGE   (Tunisia)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Adhesion; Migration; NADPH oxidase; Proliferation; Reactive oxygen species; eudesmol

Indexed keywords

BETA EUDESMOL; COLLAGEN TYPE 4; FIBRONECTIN; LAMININ; SUPEROXIDE; VITRONECTIN; ANTINEOPLASTIC AGENT; BETA-EUDESMOL; SESQUITERPENE;

A549 CELL LINE; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CACO 2 CELL LINE; CANCER CELL; CELL ADHESION; CELL DAMAGE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; COLON ADENOCARCINOMA; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GERMANDER; GROWTH INHIBITION; HT 29 CELL LINE; HUMAN; HUMAN CELL; LUNG CANCER; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; TEUCRIUM RAMOSISSIMUM; A-549 CELL LINE; CACO-2 CELL LINE; CELL CULTURE TECHNIQUE; CELL MOTION; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; HT-29 CELL LINE; ISOLATION AND PURIFICATION; METABOLISM;

A549 CELLS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CACO-2 CELLS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HT29 CELLS; HUMANS; SESQUITERPENES, EUDESMANE; SUPEROXIDES; TEUCRIUM;

EID: 84980335813     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2016.07.019     Document Type: Article

References (34)

1. Banfi, B., Schrenzel, J., Nusse, O., Lew, D.P., Ligeti, E., Krause, K.H., et al. A novel H(+) conductance in eosinophils: unique characteristics and absence in chronic granulomatous disease. J. Exp. Med. 190 (1999), 183–194.
2. Bazaa, A., Luis, J., Srairi-Abid, N., Kallech-Ziri, O., Kessentini-Zouari, R., Defilles, C., et al. MVL-PLA2, a phospholipase A2 from Macrovipera lebetina transmediterranea venom, inhibits tumor cells adhesion and migration. Matrix Biol. 28 (2009), 188–193.
3. Bedard, K., Krause, K.H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87 (2007), 245–313.
4. Ben Sghaier, M., Harizi, H., Louhichi, T., Krifa, M., Ghedira, K., Chekir-Ghedira, L., Anti-inflammatory and antiulcerogenic activities of leaf extracts and sesquiterpene from Teucrium ramosissimum (Lamiaceae). Immunopharmacol. Immunotoxicol. 33:4 (2011), 656–662.
5. Ben Sghaier, M., Skandrani, I., Nasr, N., Dijoux Franca, M.G., Chekir-Ghedira, L., Ghedira, K., Flavonoids and sesquiterpenes from Tecurium ramosissimum promote antiproliferation of human cancer cells and enhance antioxidant activity: a structure-activity relationship study. Environ. Toxicol. Pharmacol. 32 (2011), 336––348.
6. Benhar, M., Dalyot, I., Engelberg, D., Levitzki, A., Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol. Cell Biol. 21 (2001), 6913–6926.
7. Chou, T.C., Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58 (2006), 621–681.
8. Cravotto, G., Boffa, L., Genzini, L., Garella, D., Phytotherapeutics: an evaluation of the 1000 plants. J. Clin. Pharm. Ther. 35:1 (2010), 11–48.
9. D'Autreaux, B., Toledano, M.B., ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 8 (2007), 813–824.
10. Dahan, L., Sadok, A., Formento, J.L., Seitz, J.F., Kovacic, H., Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines. Brit. J. Pharmacol. 158 (2009), 610–620.
11. Delamarre, E., Taboubi, S., Mathieu, S., Berenguer, C., Rigot, V., Lissitzky, J.C., et al. Expression of integrin alpha6beta1 enhances tumorigenesis in glioma cells. Am. J. Pathol. 175 (2009), 844–855.
12. Dhillon, A.S., Hagan, S., Rath, O., Kolch, W., MAP kinase signalling pathways in cancer. Oncogene 26 (2007), 3279–3290.
13. Drummond, G.R., Selemidis, S., Griendling, K.K., Sobey, C.G., Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 10 (2011), 453–471.
14. Hordijk, P.L., Regulation of NADPH oxidases: the role of Rac proteins. Circ. Res. 98 (2006), 453–462.
15. Hynes, R.O., Integrins: bidirectional allosteric signaling machines. Cell 110 (2002), 673–687.
16. Irani, K., Xia, Y., Zweier, J.L., Sollott, S.J., Der, C.J., Fearon, E.R., et al. Mitogenic signaling mediated by oxidants in Ras transformed fibroblasts. Science 275 (1997), 1649–1652.
17. Kenny, L.M., Coombes, R.C., Oulie, I., Contractor, K.B., Miller, M., Spinks, T.J., Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients. J. Nucl. Med. 49 (2008), 879–886.
18. Kimura, M., Kimura, I., Kondoh, T., Tsuneki, H., Noncontractile acetylcholine receptor-operated Ca++ mobilization: suppression of activation by open channel blockers and acceleration of desensitization by closed channel blockers in mouse diaphragm muscle. J. Pharmacol. Exp. Ther. 256 (1991), 18–23.
19. Kimura, M., Nojima, H., Muroi, M., Kimura, I., Mechanism of the blocking action of β-eudesmol on the nicotinic acetylcholine receptor channel in mouse skeletal muscles. Neuropharmacology 30 (1991), 835–841.
20. Kolarova, H., Bino, L., Pejchalova, K., Kubala, L., The expression of NADPH oxidases and production of reactive oxygen species by human lung adenocarcinoma epithelial cell line A549. Folia Biol. 56 (2010), 211–217.
21. Laurent, E., McCoy, J.W., Macina, R.A., Liu, W., Cheng, G., Robine, S., Papkoff, J., Lambeth, J.D., Nox1 is over-expressed in human colon cancers and correlates with activating mutations in K-Ras. Int. J. Cancer 123 (2008), 100–107.
22. Liou, G.Y., Storz, P., Reactive oxygen species in cancer. Free Radic. Res. 44 (2010), 479–496.
23. Ma, E.L., Li, Y.C., Tsuneki, H., Xiao, J.F., Xia, M.Y., Wang, M.W., et al. β-eudesmol suppresses tumour growth through inhibition of tumour neovascularisation and tumour cell proliferation. J. Asian Nat. Prod. Res. 10:1–2 (2008), 159–167.
24. Obara, Y., Aoki, T., Kusano, M., Ohizumi, Y., β-eudesmol induces neurite outgrowth in rat pheochromocytoma cells accompanied by an activation of mitogen-activated protein kinase. J. Pharmacol. Exp. Ther. 301 (2002), 803–811.
25. Rigot, V., Lehmann, M., André, F., Daemi, N., Marvaldi, J., Luis, J., Integrin ligation and PKC activation are required for migration of colon carcinoma cells. J. Cell Sci. 111:Pt. 20 (1998), 3119–3127.
26. Rodrigues, P., de Marco, G., Furriol, J., Mansego, M.L., Pineda-Alonso, M., Gonzalez-Neira, A., Martin-Escudero, J.C., Benitez, J., Lluch, A., Chaves, F.J., Eroles, P., Oxidative stress in susceptibility to breast cancer: study in Spanish population. BMC Cancer, 14, 2014, 861.
27. Rosso, F., Giordano, A., Barbarisi, M., Barbarisi, A., From cell-ECM interactions to tissue engineering. J. Cell. Physiol. 19:2 (2004), 174–180.
28. Sadok, A., Bourgarel-Rey, V., Gattacceca, F., Penel, C., Lehmann, M., Kovacic, H., Nox1-dependent superoxide production controls colon adenocarcinoma cell migration. Biochim. Biophys. Acta 1783 (2008), 23–33.
29. Suh, Y.A., Arnold, R.S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., et al. Cell transformation by the superoxidegenerating oxidase Mox1. Nature 401 (1999), 79–82.
30. Thomas, G.J., Lewis, M.P., Hart, I.R., Marshall, J.F., Speight, P.M., AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int. J. Cancer 92 (2001), 641–650.
31. Tsai, Y.M., Yang, C.J., Hsu, Y.L., Wu, L.Y., Tsai, Y.C., Hung, J.Y., et al. Glabridin inhibits migration, invasion, and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting the FAK/rho signaling pathway. Integr. Cancer Ther. 10:4 (2010), 341–349.
32. Tsuneki, H., Ma, E.L., Kobayashi, S., Sekizaki, N., Maekawa, K., Sasaoka, T., et al. Antiangiogenic activity of β-eudesmol in vitro and in vivo. Eur. J. Pharmacol. 512 (2005), 105–115.
33. Yamazaki, D., Kurisu, S., Takenawa, T., Regulation of cancer cell motility through actin reorganization. Cancer Sci. 96:7 (2005), 379–386.
34. Yatogho, T., Izumi, M., Kashiwagi, H., Hayashi, M., Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct. Funct. 13 (1988), 281–292.